Search research articles
Contact Us
Filters
Showing results (271-280 of 279) with videos related to
Page
of 28
Sort By:
You have reached the last page of results.
This site can display upto 279 results.
Science Bulletin
|
January 20, 2023
Pediatric reference intervals in China (PRINCE): design and rationale for a large, multicenter collaborative cross-sectional study
Xin Ni, Wenqi Song, Xiaoxia Peng, et al.
Molecular Cancer Therapeutics
|
December 9, 2024
KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule Inhibitors
Yogesh K Chutake, Michele F Mayo, Nancy Dumont, et al.
Journal of Medicinal Chemistry
|
August 16, 2024
Discovery of KT-474─a Potent, Selective, and Orally Bioavailable IRAK4 Degrader for the Treatment of Autoimmune Diseases
Xiaozhang Zheng, Nan Ji, Veronica Campbell, et al.
Journal of Medicinal Chemistry
|
April 16, 2019
Structure Overhaul Affords a Potent Purine PI3Kδ Inhibitor with Improved Tolerability
Joey L Methot, Hua Zhou, Sam D Kattar, et al.
Nature Medicine
|
November 13, 2023
IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial
Lindsay Ackerman, Gerard Acloque, Sandro Bacchelli, et al.
Journal of Medicinal Chemistry
|
April 2, 2021
Projected Dose Optimization of Amino- and Hydroxypyrrolidine Purine PI3Kδ Immunomodulators
Joey L Methot, Hua Zhou, Meredeth A McGowan, et al.
Journal of Medicinal Chemistry
|
October 29, 2021
Discovery of <b>MK-4688</b>: an Efficient Inhibitor of the HDM2-p53 Protein-Protein Interaction
Michael H Reutershan, Michelle R Machacek, Michael D Altman, et al.
Journal of Medicinal Chemistry
|
March 23, 2021
The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer
Ryan V Quiroz, Michael H Reutershan, Sebastian E Schneider, et al.
Respiratory Medicine
|
October 5, 2024
The impact of the COVID-19 pandemic on RSV outbreaks in children: A multicenter study from China
Teng Zhou, Dapeng Chen, Qiang Chen, et al.
Page
of 28
Search research articles
Search
Showing results (271-280 of 279) with videos related to
Sort By:
Page
of 28
You have reached the last page of results.
This site can display upto 279 results.
Science Bulletin
|
January 20, 2023
Pediatric reference intervals in China (PRINCE): design and rationale for a large, multicenter collaborative cross-sectional study
Xin Ni, Wenqi Song, Xiaoxia Peng, et al.
Molecular Cancer Therapeutics
|
December 9, 2024
KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule Inhibitors
Yogesh K Chutake, Michele F Mayo, Nancy Dumont, et al.
Journal of Medicinal Chemistry
|
August 16, 2024
Discovery of KT-474─a Potent, Selective, and Orally Bioavailable IRAK4 Degrader for the Treatment of Autoimmune Diseases
Xiaozhang Zheng, Nan Ji, Veronica Campbell, et al.
Journal of Medicinal Chemistry
|
April 16, 2019
Structure Overhaul Affords a Potent Purine PI3Kδ Inhibitor with Improved Tolerability
Joey L Methot, Hua Zhou, Sam D Kattar, et al.
Nature Medicine
|
November 13, 2023
IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial
Lindsay Ackerman, Gerard Acloque, Sandro Bacchelli, et al.
Journal of Medicinal Chemistry
|
April 2, 2021
Projected Dose Optimization of Amino- and Hydroxypyrrolidine Purine PI3Kδ Immunomodulators
Joey L Methot, Hua Zhou, Meredeth A McGowan, et al.
Journal of Medicinal Chemistry
|
October 29, 2021
Discovery of <b>MK-4688</b>: an Efficient Inhibitor of the HDM2-p53 Protein-Protein Interaction
Michael H Reutershan, Michelle R Machacek, Michael D Altman, et al.
Journal of Medicinal Chemistry
|
March 23, 2021
The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer
Ryan V Quiroz, Michael H Reutershan, Sebastian E Schneider, et al.
Respiratory Medicine
|
October 5, 2024
The impact of the COVID-19 pandemic on RSV outbreaks in children: A multicenter study from China
Teng Zhou, Dapeng Chen, Qiang Chen, et al.
Page
of 28